MYL Related Rumors
-
Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies
-
Valeant (VRX), Mylan (MYL) on Watch as Actavis (ACT) Buys Warner Chilcott (WCRX)
-
UPDATE: Correct: Buying Warner Chilcott plc (WCRX) Seen as Takeover Defense by Actavis (ACT)
-
Warner Chilcott (WCRX) Volatile as Actavis (ACT) Has a New Bidder
-
Actavis (ACT) said to have turned away $15 billion bid from Mylan (MYL) - Bloomberg
-
Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'
-
Par Pharmaceutical (PRX) Peers On Watch After Deal (TEVA) (MYL) (WPI)
-
Mylan (MYL) Receives FDA Approval for Generic Version of Takeda's Actoplus Met
-
Goldman Sachs Sees Mylan (MYL) as a Strong Takeover Target
-
Watson Pharma (WPI) May Pay $6B for Mysterious Swiss Drug Maker
-
Canaccord Genuity on Life Sciences/Specialty Pharma: What an Actavis Deal Could Mean to Watson (WPI) and the Sector
-
Mylan (MYL) Highlighted Option Trade on M&A Potential
-
Goldman Sachs Cranks Price Target On Mylan (MYL) Up to $28 On Potential M&A
-
Mylan (MYL) Sees a Slight Bid On Pfizer's Takeover of King Pharma
-
Mylan (MYL) Sees Upside On Buyout Rumor
-
Wachovia Comments on Mylan (MYL) After TEVA/BRL Merger
-
UPDATE: Mylan Labs (MYL) Higher on Renewed Takeover Speculation
-
Mylan Labs (MYL) Higher on Renewed Takeover Speculation
-
Citigroup offers six predictions for specialty pharma in 2006
-
Rumors of KG Takeover Resurface
-
KG Makes New 52-wk High; Rumors Persist
-
KG Shaply Higher; Rumors of New MYL Bid
-
Hearing MYL Could Entertain a Bid for KG Again
-
Icahn Affiliate High River Confirms It Tendered 26.3M MYL Shares
-
Ichan May Have Tendered Shares to Mylan
-
Ichan Led Group Offers to Buy MYL for $20/Sh
-
Is KG Back on the Auction Block?
-
Mylan and King Pharma Call Off Merger
-
Icahn To Nominate Slate of MYL Directors
-
Big Pharma Looking Acquisitive - WSJ
Back to MYL Stock Lookup
